CompletedNCT05273567
A Trial of Guanfacine-er for Addiction
Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: June 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 22
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05273567
- Official title
Show the full official title
A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder
Get this study by email
Recruitment & locations
CompletedNew York
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including guanfacine-ER.
Who was this study for?
Listed age limits: 18 years to 65 years.
